Logos Global Management’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-875,000
| Closed | -$37M | – | 56 |
|
2024
Q4 | $37M | Buy |
875,000
+375,000
| +75% | +$15.9M | 4.33% | 5 |
|
2024
Q3 | $22.1M | Sell |
500,000
-450,000
| -47% | -$19.9M | 2.38% | 17 |
|
2024
Q2 | $34.4M | Buy |
950,000
+375,000
| +65% | +$13.6M | 2.76% | 9 |
|
2024
Q1 | $24.8M | Buy |
+575,000
| New | +$24.8M | 2.01% | 15 |
|
2023
Q1 | – | Sell |
-285,000
| Closed | -$5.51M | – | 48 |
|
2022
Q4 | $5.51M | Buy |
+285,000
| New | +$5.51M | 0.65% | 32 |
|
2022
Q2 | – | Sell |
-385,000
| Closed | -$9.04M | – | 41 |
|
2022
Q1 | $9.04M | Buy |
385,000
+335,000
| +670% | +$7.87M | 1.17% | 23 |
|
2021
Q4 | $1.34M | Buy |
+50,000
| New | +$1.34M | 0.14% | 59 |
|